ValiRx shares drop after cancer drug research dropped
(Alliance News) - ValiRx PLC shares fell on Friday, after it ended its evaluation agreement with Hokkaido University to research a potential drug.
Read moreWed, 01st Apr 2020 13:57
(Alliance News) - ValiRx PLC shares fell on Friday, after it ended its evaluation agreement with Hokkaido University to research a potential drug.
Read more(Alliance News) - Stock prices in London opened higher on Friday, taking their cue from Asian and US equities, while investors weighed recent interest rate decisions.
Read more(Sharecast News) - Life science company ValiRx has successfully completed the acquisition of the scientific assets of Imagen Therapeutics, it announced on Wednesday.
Read more(Alliance News) - ValiRx PLC on Wednesday said it acquired the scientific assets of Imagen Therapeutics Ltd from its appointed liquidators for GBP170,000.
Read more(Alliance News) - ValiRx PLC on Wednesday said it has expanded a pre-existing agreement with the University of Barcelona to test additional molecules as possible drugs for cancer.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
Read more(Sharecast News) - Life science company ValiRx announced the incorporation of a new wholly-owned subsidiary, Inaphaea BioLabs, on Wednesday.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Read moreFriday 27 January | |
Avon Protection PLC | AGM |
Henderson Far East Income Ltd | AGM |
Ixico PLC | AGM |
NB Global Monthly Income Fund Ltd | EGM re proposed managed wind-down |
On The Beach Group PLC | AGM |
Pathfinder Minerals PLC | GM re capital raise |
Serica Energy PLC | GM re consideration shares approval |
Treatt PLC | AGM |
Monday 30 January | |
Bluebird Merchant Ventures Ltd | AGM |
Contango Holdings PLC | AGM |
Hollywood Bowl Group PLC | AGM |
SkinBioTherapeutics PLC | GM re annual report review |
Starwood European Real Estate Finance Ltd | EGM re capital return |
Webis Holdings PLC | AGM |
Tuesday 31 January | |
Hydrogen Future Industries PLC | AGM |
Mobile Streams PLC | AGM |
Residential Secure Income PLC | AGM (TBC) |
Star Phoenix Group Ltd | GM re removal and appointment of auditor |
Team PLC | AGM |
Yamana Gold Inc | SGM re transaction with Agnico Eagle Mines Ltd and Pan American Silver Corp |
Zamaz PLC | AGM |
Wednesday 1 February | |
Baronsmead Second Venture Trust PLC | AGM |
Baronsmead Venture Trust PLC | AGM |
Capricorn Energy PLC | GM re directors removal and appointment of new directors |
Catalyst Media Group | AGM |
Hyve Group PLC | AGM |
Imperial Brands PLC | AGM |
Premier Miton Group PLC | AGM |
Renew Holdings PLC | AGM |
Schroder Asia Pacific Fund PLC | AGM |
Thursday 2 February | |
abrdn Equity Income Trust PLC | AGM |
Alteration Earth PLC | AGM |
Baillie Gifford European Growth Trust PLC | AGM |
JPMorgan Indian Investment Trust PLC | AGM |
Sage Group PLC | AGM |
Schroder European Real Estate Investment Trust PLC | AGM |
Tectonic Gold PLC | AGM |
ValiRx PLC | GM re fundraising |
Copyright 2023 Alliance News Ltd. All Rights Reserved. |
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Read moreValiRx PLC - Hatfield Heath, England-based life sciences company focused on early-stage cancer therapeutics and women's health - Raises GBP1 million from placing of 9.1 million shares at 11 pence each. Also will raise up to GBP500,000 more from a broker offer to retail investors at the same price. Turner Pope Investments Ltd will run the broker offer. Every four shares in the placing and retail offer come with a warrant to buy another new share at 14p over the next three years. Calls February 2 general meeting to approve the fund raise. Currently has a GBP10.1 million market capitalisation.
Read more(Alliance News) - ValiRx PLC on Tuesday saw shares drop, after extending its evaluation agreement with Hokkaido University to conduct further experimental testing.
Read more(Sharecast News) - Women's health and cancer therapeutics company ValiRx announced the formation of a new partially-owned subsidiary, Cytolytix, on Monday, which had signed an intellectual property licence agreement with King's College London (KCL).
Read more(Alliance News) - ValiRx PLC on Monday said it is making progress on its goal to introduce new academic projects into its portfolio, after launching subsidiary company Cytolytix Ltd and signing a licence agreement with King's College London.
Read more